Activist investor
Kohl’s shareholders are expected to reject all 10 nominees that Macellum put forward for the board, according to people familiar with the situation. Kohl’s declined to comment. Macellum wasn’t immediately available to comment.
The results were a blow to Macellum, which has a Kohl’s stake of nearly 5% and has been pressuring the company for two years to overhaul ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
